Cargando…
Fusion protein technologies for biopharmaceuticals : applications and challenges /
The state of the art in biopharmaceutical FUSION PROTEIN DESIGN Fusion proteins belong to the most lucrative biotech drugs-with Enbrel® being one of the best-selling biologics worldwide. Enbrel® represents a milestone of modern therapies just as Humulin®, the first therapeutic recombinant protein fo...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Hoboken, New Jersey :
John Wiley & Sons,
©2013.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn811850420 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 121002s2013 nju ob 001 0 eng | ||
| 010 | |a 2012040270 | ||
| 040 | |a DLC |b eng |e pn |c DLC |d YDX |d DG1 |d N$T |d YDXCP |d E7B |d CDX |d IDEBK |d COO |d NOC |d OCLCF |d CCO |d NLGGC |d RECBK |d EBLCP |d OCLCQ |d OCLCO |d D6H |d LOA |d DG1 |d CHVBK |d MOR |d LIP |d PIFAG |d OCLCQ |d MERUC |d OCLCQ |d DEBBG |d GWDNB |d MERER |d ZCU |d U3W |d COCUF |d OCLCQ |d CASUM |d OCLCO |d STF |d WRM |d OCLCQ |d NRAMU |d ICG |d INT |d VT2 |d OCLCO |d AU@ |d OCLCO |d WYU |d OCLCQ |d UWO |d OCLCO |d OCLCQ |d YOU |d OCLCO |d OCLCQ |d U3G |d OCLCQ |d DKC |d OCLCO |d OCLCQ |d CEF |d OCLCQ |d HS0 |d ADU |d OCLCQ |d OCLCA |d SNU |d LUN |d REDDC |d VHC |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCL | ||
| 016 | 7 | |a 1064375278 |2 DE-101 | |
| 016 | 7 | |a 1064373186 |2 DE-101 | |
| 019 | |a 828793860 |a 899179767 |a 961568624 |a 962707379 |a 966257693 |a 988439035 |a 992034563 |a 992885863 |a 1018038563 |a 1023008081 |a 1037742715 |a 1038586354 |a 1044955578 |a 1045520766 |a 1053540316 |a 1058073775 |a 1058532784 |a 1097116970 |a 1097135402 |a 1100215356 |a 1100832644 |a 1113203046 |a 1119025295 |a 1148132188 |a 1162121834 |a 1170969771 |a 1171968374 |a 1290072238 |a 1292982777 |a 1303520746 | ||
| 020 | |a 9781118354582 |q (epub) | ||
| 020 | |a 1118354583 |q (epub) | ||
| 020 | |a 9781118354575 |q (pdf) | ||
| 020 | |a 1118354575 |q (pdf) | ||
| 020 | |a 9781118354568 |q (mobi) | ||
| 020 | |a 1118354567 |q (mobi) | ||
| 020 | |a 9781118354599 |q (electronic bk.) | ||
| 020 | |a 1118354591 |q (electronic bk.) | ||
| 020 | |a 9781299241954 |q (MyiLibrary) | ||
| 020 | |a 1299241956 |q (MyiLibrary) | ||
| 020 | |z 9780470646274 |q (cloth) | ||
| 020 | |z 0470646276 |q (cloth) | ||
| 029 | 1 | |a AU@ |b 000050086446 | |
| 029 | 1 | |a CHBIS |b 009914530 | |
| 029 | 1 | |a CHNEW |b 000940678 | |
| 029 | 1 | |a CHVBK |b 480209812 | |
| 029 | 1 | |a DEBBG |b BV043395079 | |
| 029 | 1 | |a DEBBG |b BV044049944 | |
| 029 | 1 | |a DEBSZ |b 485027534 | |
| 029 | 1 | |a GWDNB |b 1064373186 | |
| 029 | 1 | |a GWDNB |b 1064375278 | |
| 029 | 1 | |a NZ1 |b 15340367 | |
| 029 | 1 | |a NZ1 |b 15905471 | |
| 029 | 1 | |a AU@ |b 000070388381 | |
| 035 | |a (OCoLC)811850420 |z (OCoLC)828793860 |z (OCoLC)899179767 |z (OCoLC)961568624 |z (OCoLC)962707379 |z (OCoLC)966257693 |z (OCoLC)988439035 |z (OCoLC)992034563 |z (OCoLC)992885863 |z (OCoLC)1018038563 |z (OCoLC)1023008081 |z (OCoLC)1037742715 |z (OCoLC)1038586354 |z (OCoLC)1044955578 |z (OCoLC)1045520766 |z (OCoLC)1053540316 |z (OCoLC)1058073775 |z (OCoLC)1058532784 |z (OCoLC)1097116970 |z (OCoLC)1097135402 |z (OCoLC)1100215356 |z (OCoLC)1100832644 |z (OCoLC)1113203046 |z (OCoLC)1119025295 |z (OCoLC)1148132188 |z (OCoLC)1162121834 |z (OCoLC)1170969771 |z (OCoLC)1171968374 |z (OCoLC)1290072238 |z (OCoLC)1292982777 |z (OCoLC)1303520746 | ||
| 037 | |n Title subscribed to via ProQuest Academic Complete | ||
| 042 | |a pcc | ||
| 050 | 0 | 0 | |a RM301.4 |b .F87 2013 |
| 060 | 4 | |a QU 450 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 0 | 0 | |a 615.7 |2 23 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Fusion protein technologies for biopharmaceuticals : |b applications and challenges / |c edited by Stefan R. Schmidt. |
| 260 | |a Hoboken, New Jersey : |b John Wiley & Sons, |c ©2013. | ||
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file |2 rda | ||
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record and CIP data provided by publisher. | |
| 505 | 0 | |a pt. 1. Introduction -- pt. 2. The triple t paradigm : time, toxin, targeting -- pt. 3. Beyond the triple t-paradigm. | |
| 520 | |a The state of the art in biopharmaceutical FUSION PROTEIN DESIGN Fusion proteins belong to the most lucrative biotech drugs-with Enbrel® being one of the best-selling biologics worldwide. Enbrel® represents a milestone of modern therapies just as Humulin®, the first therapeutic recombinant protein for human use, approved by the FDA in 1982 and Orthoclone® the first monoclonal antibody reaching the market in 1986. These first generation molecules were soon followed by a plethora of recombinant copies of natural human proteins, and in 1998, the first de novo designed fusion protei. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Biopharmaceutics. | |
| 650 | 0 | |a Pharmaceutical biotechnology. | |
| 650 | 0 | |a Drug carriers (Pharmacy) | |
| 650 | 0 | |a Protein engineering. | |
| 650 | 0 | |a Recombinant proteins. | |
| 650 | 1 | 2 | |a Recombinant Fusion Proteins |x therapeutic use |
| 650 | 2 | 2 | |a Drug Carriers |
| 650 | 2 | 2 | |a Immunotoxins |x pharmacokinetics |
| 650 | 2 | 2 | |a Immunotoxins |x therapeutic use |
| 650 | 2 | 2 | |a Protein Engineering |
| 650 | 2 | 2 | |a Recombinant Fusion Proteins |x pharmacokinetics |
| 650 | 2 | |a Biopharmaceutics | |
| 650 | 2 | |a Pharmaceutical Vehicles | |
| 650 | 2 | |a Recombinant Proteins | |
| 650 | 6 | |a Protéines recombinantes. | |
| 650 | 6 | |a Biopharmacie. | |
| 650 | 6 | |a Biotechnologie pharmaceutique. | |
| 650 | 6 | |a Vecteurs de médicaments. | |
| 650 | 6 | |a Technologie des protéines. | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Recombinant proteins |2 fast | |
| 650 | 7 | |a Protein engineering |2 fast | |
| 650 | 7 | |a Drug carriers (Pharmacy) |2 fast | |
| 650 | 7 | |a Biopharmaceutics |2 fast | |
| 650 | 7 | |a Pharmaceutical biotechnology |2 fast | |
| 655 | 4 | |a Internet Resources. | |
| 700 | 1 | |a Schmidt, Stefan R. | |
| 758 | |i has work: |a Fusion Protein Technologies for Biopharmaceuticals Applications and Challenges (Text) |1 https://id.oclc.org/worldcat/entity/E39PCXVTbKT9R7ttC8Gjqrj8JC |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Fusion protein technologies for biopharmaceuticals. |d Hoboken, N.J. : John Wiley & Sons, ©2013 |z 9780470646274 |w (DLC) 2012039440 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1119446 |z Texto completo |
| 938 | |a Coutts Information Services |b COUT |n 23452133 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL1119446 | ||
| 938 | |a ebrary |b EBRY |n ebr10662566 | ||
| 938 | |a EBSCOhost |b EBSC |n 542817 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n cis24878973 | ||
| 938 | |a Recorded Books, LLC |b RECE |n rbeEB00063420 | ||
| 938 | |a YBP Library Services |b YANK |n 10247619 | ||
| 938 | |a YBP Library Services |b YANK |n 9571140 | ||
| 938 | |a YBP Library Services |b YANK |n 10253195 | ||
| 994 | |a 92 |b IZTAP | ||